Publications by authors named "Hans Bojar"

Claim this Profile
C
Correction to: The role of passive immunization in the age of SARS-CoV-2: an update.
Johannes C Fischer, Kurt Zänker, Martijn van Griensven, Marion Schneider, Detlef Kindgen-Milles, Hans Bojar

Eur J Med Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of passive immunization in the age of SARS-CoV-2: an update.
Johannes C Fischer, Kurt Zänker, Martijn van Griensven, Marion Schneider, Detlef Kindgen-Milles, Hans Bojar

Eur J Med Res· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia and Interleukin-2.
Ralf Kleef, Ralph Moss, A Marcell Szasz, Arthur Bohdjalian, Hans Bojar

Integr Cancer Ther· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer.
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, Guido Hennig, Kerstin Bohmann, Hans Bojar

Virchows Arch· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased CD44s and decreased CD44v6 RNA expression are associated with better survival in myxofibrosarcoma patients: a pilot study.
Christiane Matuschek, Marcus Lehnhardt, Peter Arne Gerber, Christopher Poremba, Jackson Hamilton, Hans Bojar

Eur J Med Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comprehensive analysis of human gene expression profiles identifies stromal immunoglobulin κ C as a compatible prognostic marker in human solid tumors.
Marcus Schmidt, Birte Hellwig, Seddik Hammad, Amnah Othman, Miriam Lohr, Hans Bojar

Clin Cancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective study of neoadjuvant versus adjuvant radiochemotherapy in locally advanced noninflammatory breast cancer : survival advantage in cT2 category by neoadjuvant radiochemotherapy.
Stephan Ludwig Roth, Werner Audretsch, Hans Bojar, Innokentij Lang, Reinhart Willers

Strahlenther Onkol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction.
Jan C Brase, Marcus Schmidt, Thomas Fischbach, Holger Sültmann, Hans Bojar

Clin Cancer Res· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression of circulating tumour cells in breast cancer patients.
E Bölke, K Orth, P A Gerber, G Lammering, R Mota, Hans Bojar

Eur J Med Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ERK1/2 is highly phosphorylated in melanoma metastases and protects melanoma cells from cisplatin-mediated apoptosis.
Alireza Mirmohammadsadegh, Rodrigo Mota, Annett Gustrau, Mohammed Hassan, Sandeep Nambiar, Hans Bojar

J Invest Dermatol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
Christopher Kramer, Kai Klasmeyer, Hans Bojar, Wolfgang A Schulz, Rolf Ackermann

Cancer· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can a 70-gene signature provide useful prognostic information in patients with node-negative breast cancer?
Olga Modlich, Hans Bojar

Nat Clin Pract Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression analysis of pancreatic cancer cell lines reveals association of enhanced gene transcription and genomic amplifications at the 8q22.1 and 8q24.22 loci.
Dirk Domagk, Karl-Ludwig Schaefer, Martin Eisenacher, Yvonne Braun, Daniel H Wai, Hans Bojar

Oncol Rep· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT5 phosphorylation in malignant melanoma is important for survival and is mediated through SRC and JAK1 kinases.
Alireza Mirmohammadsadegh, Mohamad Hassan, Walter Bardenheuer, Alessandra Marini, Annett Gustrau, Hans Bojar

J Invest Dermatol· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer expression profiling: the impact of microarray testing on clinical decision making.
Olga Modlich, Hans-Bernd Prisack, Hans Bojar

Expert Opin Pharmacother· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression in acute Stanford type A dissection: a comparative microarray study.
Barbara Theresia Weis-Müller, Olga Modlich, Irina Drobinskaya, Derya Unay, Rita Huber, Hans Bojar

J Transl Med· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.
Hans-Bernd Prisack, Christiaan Karreman, Olga Modlich, Werner Audretsch, Mahmoud Danae, Hans Bojar

Anticancer Res· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures.
Olga Modlich, Hans-Bernd Prisack, Marc Munnes, Werner Audretsch, Hans Bojar

J Transl Med· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy by gene transfer with plasmids encoding IL-12/IL-18 is superior to IL-23/IL-18 gene transfer in a rat osteosarcoma model.
Christian Liebau, Christian Roesel, Sebastian Schmidt, Christiaan Karreman, Johannes Bernd Prisack, Hans Bojar

Anticancer Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer disease.
Olga Modlich, Hans-Bernd Prisack, Marc Munnes, Werner Audretsch, Hans Bojar

Clin Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Olga Modlich, Hans-Bernd Prisack, Gerald Pitschke, Uwe Ramp, Rolf Ackermann, Hans Bojar

Clin Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-12 and interleukin-18 change ICAM-I expression, and enhance natural killer cell mediated cytolysis of human osteosarcoma cells.
Christian Liebau, Harry Merk, Sebastian Schmidt, Christian Roesel, Christiaan Karreman, Hans Bojar

Cytokines Cell Mol Ther· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vector.
Ulrich-Peter Rohr, Marc-Andre Wulf, Susanne Stahn, Florian Heyd, Ulrich Steidl, Hans Bojar

Cancer Gene Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
rIL-18 triggered gene therapy based on a transduction with the IL-12 plasmid: a new option as immuno-therapy for osteosarcoma?
Christian Liebau, Harry Merk, Christian Roesel, Sebastian Schmidt, Christiaan Karreman, Hans Bojar

Anticancer Res· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer families.
Vera Balz, Hans Bernd Prisack, Henning Bier, Hans Bojar

Cancer Genet Cytogenet· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis